Natixis Advisors LLC Has $1.39 Million Stake in Doximity, Inc. (NASDAQ:DOCS)

Natixis Advisors LLC increased its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 43.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,815 shares of the company's stock after acquiring an additional 9,644 shares during the period. Natixis Advisors LLC's holdings in Doximity were worth $1,386,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the stock. GAMMA Investing LLC increased its position in Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock worth $63,000 after buying an additional 412 shares during the last quarter. Van ECK Associates Corp increased its holdings in shares of Doximity by 19.7% during the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company's stock worth $72,000 after acquiring an additional 427 shares during the last quarter. Cornercap Investment Counsel Inc. raised its stake in Doximity by 3.2% in the 2nd quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company's stock valued at $479,000 after acquiring an additional 537 shares during the period. Farther Finance Advisors LLC lifted its holdings in Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. Finally, KBC Group NV boosted its position in Doximity by 22.9% during the third quarter. KBC Group NV now owns 3,296 shares of the company's stock worth $144,000 after purchasing an additional 614 shares during the period. 87.19% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on DOCS. The Goldman Sachs Group started coverage on shares of Doximity in a report on Friday, November 15th. They issued a "neutral" rating and a $58.00 price target on the stock. Robert W. Baird upped their price objective on Doximity from $41.00 to $45.00 and gave the company an "outperform" rating in a report on Tuesday, September 17th. Truist Financial lifted their target price on Doximity from $35.00 to $49.00 and gave the stock a "hold" rating in a report on Thursday, November 14th. Needham & Company LLC raised shares of Doximity from a "hold" rating to a "buy" rating and set a $38.00 price target on the stock in a research report on Friday, August 9th. Finally, Canaccord Genuity Group downgraded shares of Doximity from a "buy" rating to a "hold" rating and boosted their price objective for the company from $40.00 to $60.00 in a report on Wednesday, November 13th. Eleven equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $52.27.

Doximity Trading Down 0.2 %

DOCS traded down $0.10 on Wednesday, reaching $53.44. The stock had a trading volume of 2,064,183 shares, compared to its average volume of 1,765,324. The firm has a 50-day moving average of $45.10 and a 200-day moving average of $35.55. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75. The company has a market capitalization of $9.98 billion, a price-to-earnings ratio of 61.43, a price-to-earnings-growth ratio of 3.91 and a beta of 1.30.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.